an interview with

Mark S. Blumenkranz, MD

Innovation has been a central theme in the extraordinary life and career of Mark S. Blumenkranz, MD. He is the innovator of truly pivotal vitrectomy surgery techniques and instruments, as well as clinical drug studies that helped usher in the modern era of intravitreal surgical and drug therapy. As the HU Smead Professor Emeritus and co-director of the Ophthalmic Innovation Program at the Byers Eye Institute at Stanford University School of Medicine, Dr. Blumenkranz is in a rare class of physicians that has made medical entrepreneurship look easy, having founded, co-founded or directed over 15 entrepreneurial ventures. Listen in as he shares first-hand accounts of remarkable advances in retina over the course of his truly remarkable career.